H3 G34 mutation assessment for diffuse gliomas in adults: when would testing be most diagnostically useful? Trejo-Lopez JA, Praska CE, Zepeda Mendoza C, Kollmeyer TM, et al. J Neuropathol Exp Neurol 2022 Nov 3. pii: 6795064. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Trejo-Lopez JA, Praska CE, Zepeda Mendoza C, Kollmeyer TM, et al. H3 G34 mutation assessment for diffuse gliomas in adults: when would testing be most diagnostically useful? J Neuropathol Exp Neurol 2022 Nov 3. pii: 6795064. doi: 10.1093.
PMID: 36326576